JP2024509332A5 - - Google Patents
Info
- Publication number
- JP2024509332A5 JP2024509332A5 JP2023573494A JP2023573494A JP2024509332A5 JP 2024509332 A5 JP2024509332 A5 JP 2024509332A5 JP 2023573494 A JP2023573494 A JP 2023573494A JP 2023573494 A JP2023573494 A JP 2023573494A JP 2024509332 A5 JP2024509332 A5 JP 2024509332A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- amino acid
- nos
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2102224.9A GB202102224D0 (en) | 2021-02-17 | 2021-02-17 | Anti-TRC delta variable 1 antibodies |
| GB2102224.9 | 2021-02-17 | ||
| GB2111685.0 | 2021-08-14 | ||
| GBGB2111685.0A GB202111685D0 (en) | 2021-08-14 | 2021-08-14 | Anti-tcr delta variable 1 antibodies |
| PCT/EP2022/054011 WO2022175414A1 (en) | 2021-02-17 | 2022-02-17 | Multispecific anti-tcr delta variable 1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509332A JP2024509332A (ja) | 2024-02-29 |
| JP2024509332A5 true JP2024509332A5 (cg-RX-API-DMAC7.html) | 2025-02-26 |
Family
ID=87849871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023573494A Pending JP2024509332A (ja) | 2021-02-17 | 2022-02-17 | 多重特異性抗ＴＣＲδ可変部１抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12312408B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4294529A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024509332A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230160254A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022222299A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023016587A2 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023011973A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL305266A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023009544A (cg-RX-API-DMAC7.html) |
| PE (1) | PE20240591A1 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12023552264A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202308120B (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201811404D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-CD137 Antibodies |
| MX2023009544A (es) * | 2021-02-17 | 2023-11-28 | Gammadelta Therapeutics Ltd | Anticuerpos anti-variable delta 1 de tcr multiespecíficos. |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003210060B2 (en) | 2002-03-22 | 2010-02-25 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| TWI452136B (zh) * | 2010-11-17 | 2014-09-11 | 中外製藥股份有限公司 | A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| GB201506423D0 (en) | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| AU2016274633B2 (en) | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| US11299708B2 (en) | 2016-05-12 | 2022-04-12 | Adicet Bio, Inc. | Methods for selective expansion of γδ T-cell populations and compositions thereof |
| GB201612520D0 (en) * | 2016-07-19 | 2016-08-31 | F-Star Beta Ltd | Binding molecules |
| EP3743081A4 (en) | 2018-01-23 | 2021-12-01 | New York University | SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR |
| AU2019344300A1 (en) | 2018-09-19 | 2021-04-22 | LAVA Therapeutics N.V. | Dual acting CD1D immunoglobulin |
| US12084500B2 (en) * | 2019-01-23 | 2024-09-10 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| CN113993893A (zh) | 2019-02-01 | 2022-01-28 | 拉法医疗有限公司 | 新cd40结合抗体 |
| JP2022545196A (ja) | 2019-08-16 | 2022-10-26 | ガンマデルタ セラピューティクス リミテッド | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| JP7764364B2 (ja) | 2019-08-16 | 2025-11-05 | ガンマデルタ セラピューティクス リミティッド | エクスビボγδ Ｔ細胞集団 |
| GB202002581D0 (en) | 2020-02-24 | 2020-04-08 | Gammadelta Therapeutics Ltd | Novel antibodies |
| AU2022224391A1 (en) | 2021-02-17 | 2023-08-24 | Gammadelta Therapeutics Ltd | Anti-tcr delta variable 1 antibodies |
| MX2023009544A (es) * | 2021-02-17 | 2023-11-28 | Gammadelta Therapeutics Ltd | Anticuerpos anti-variable delta 1 de tcr multiespecíficos. |
-
2022
- 2022-02-17 MX MX2023009544A patent/MX2023009544A/es unknown
- 2022-02-17 KR KR1020237031273A patent/KR20230160254A/ko active Pending
- 2022-02-17 JP JP2023573494A patent/JP2024509332A/ja active Pending
- 2022-02-17 AU AU2022222299A patent/AU2022222299A1/en active Pending
- 2022-02-17 EP EP22706805.3A patent/EP4294529A1/en active Pending
- 2022-02-17 PH PH1/2023/552264A patent/PH12023552264A1/en unknown
- 2022-02-17 PE PE2023002380A patent/PE20240591A1/es unknown
- 2022-02-17 IL IL305266A patent/IL305266A/en unknown
- 2022-02-17 BR BR112023016587A patent/BR112023016587A2/pt unknown
-
2023
- 2023-08-16 US US18/451,047 patent/US12312408B2/en active Active
- 2023-08-22 ZA ZA2023/08120A patent/ZA202308120B/en unknown
- 2023-09-08 CO CONC2023/0011973A patent/CO2023011973A2/es unknown
-
2024
- 2024-05-01 US US18/652,676 patent/US20240376215A1/en active Pending